Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04514341 · ClinicalTrials.gov registry record

Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up

A clinical trial, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
4
Enrollment target

NCT04514341 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04514341 has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
4 participants
Enrollment target

Study Summary

Screening for colorectal cancer (CRC) not only detects disease early when treatment is more effective but also prevents cancer by finding and removing precancerous polyps. Because many of our nation's most disadvantaged and vulnerable individuals obtain health care at federally qualified health centers, these centers play a significant role in increasing CRC screenings among the most vulnerable populations. Furthermore, the full benefits of cancer screenings must include timely and appropriate follow-up of abnormal results. Thus, the purpose of this study is to implement a multilevel intervention to increase rates of CRC screenings, follow-ups, and referrals-to-care in federally qualified health centers (FQHCs). Also, we will examine the implementation strategies used to support the implementation process and their contribution to the adoption, implementation, and sustainment of the multilevel intervention. The multilevel intervention will target three different levels of influences: organization, provider, and individual. It will have multiple components, including provider and staff education, provider reminder, provider assessment and feedback, patient reminder, and patient navigation. This study is a multilevel, three-phase, stepped wedge cluster randomized trial with four clusters of clinics from four different FQHCs. Our FQHC partners together have 40 primary care clinics and 130 primary care providers. During Phase 1, there will be a 3-month waiting period during which no intervention components will be implemented. After the 3-month waiting period, we will randomize two clusters of clinics to cross from the control to the intervention and the remaining two clusters to follow three months later. All clusters of clinics will stay at the same phase for nine months, followed by a 3-month transition period, and then cross over to the next phase. In Phase 1, we will implement provider and staff education sessions. In Phase 2, we will add provider reminders, patie

Interventions

  • BEHAVIORAL Intervention Phase 1: Provider and Staff education
  • BEHAVIORAL Intervention Phase 2: Provider and staff education + Patient reminder
  • BEHAVIORAL Intervention Phase 3: Provider and Staff education + Patient reminder + Patient navigation

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2020-09-01
Est. Completion 2023-12-31

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT04514341

The ClinicalTrials.gov registry entry for NCT04514341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Intervention Phase 1: Provider and Staff education is the first listed.

NCT04514341 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04514341 about?

NCT04514341 is a clinical study titled "Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up". Screening for colorectal cancer (CRC) not only detects disease early when treatment is more effective but also prevents cancer by finding and removing precancerous polyps. Because many of our nation's most disadvantaged and vulnerable individuals obtain health care at federally qualified health cent...

What is the current status of trial NCT04514341?

This trial is currently completed. The enrollment target is 4 participants. The study started on 2020-09-01. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT04514341?

The interventions under investigation include: Intervention Phase 1: Provider and Staff education (BEHAVIORAL), Intervention Phase 2: Provider and staff education + Patient reminder (BEHAVIORAL), Intervention Phase 3: Provider and Staff education + Patient reminder + Patient navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04514341?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.